0583 Abrocitinib modulates itch-related gene expression in lesional and peri-lesional skin organ culture and skin biopsies from atopic dermatitis patients
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S100
DOI: 10.1016/j.jid.2026.06.614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von L. Zondler und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zondler, L., Fehrholz, M., Pappelbaum, K., Piccini, I., Edelkamp, J., Bertolini, M., & Watkins, M. (2026). 0583 Abrocitinib modulates itch-related gene expression in lesional and peri-lesional skin organ culture and skin biopsies from atopic dermatitis patients. Journal of Investigative Dermatology, 146(8), S100. https://doi.org/10.1016/j.jid.2026.06.614
Vancouver
Zondler L, Fehrholz M, Pappelbaum K, Piccini I, Edelkamp J, Bertolini M, et al. 0583 Abrocitinib modulates itch-related gene expression in lesional and peri-lesional skin organ culture and skin biopsies from atopic dermatitis patients. Journal of Investigative Dermatology. 2026;146(8):S100. doi:10.1016/j.jid.2026.06.614
BibTeX
@article{Zondler2026,
author = {Zondler, L. and Fehrholz, M. and Pappelbaum, K. and Piccini, I. and Edelkamp, J. and Bertolini, M. and Watkins, M.},
title = {0583 Abrocitinib modulates itch-related gene expression in lesional and peri-lesional skin organ culture and skin biopsies from atopic dermatitis patients},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S100},
doi = {10.1016/j.jid.2026.06.614}
}
EUVIMED